Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Fish and Richardson
US Army
Merck
Argus Health
Fuji
Chinese Patent Office
Novartis
Mallinckrodt
US Department of Justice

Generated: February 25, 2018

DrugPatentWatch Database Preview

Verapamil hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for verapamil hydrochloride and what is the scope of verapamil hydrochloride freedom to operate?

Verapamil hydrochloride
is the generic ingredient in seven branded drugs marketed by Mylan, Recro Gainesville, Gd Searle Llc, Mt Adams, Abraxis Pharm, Bedford, Hospira, Intl Medication, Luitpold, Marsam Pharms Llc, Smith And Nephew, Solopak, Exela Pharma Scs Llc, Pfizer, Apotex Corp, Cadila Pharms Ltd, Glenmark Generics, Ivax Sub Teva Pharms, Par Pharm, Pliva, Sun Pharm Inds Inc, Actavis Elizabeth, Heritage Pharms Inc, Mutual Pharm, Sun Pharm Industries, Warner Chilcott, Watson Labs, and Yaopharma Co Ltd, and is included in sixty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are seventeen drug master file entries for verapamil hydrochloride. Thirty-eight suppliers are listed for this compound.
Medical Subject Heading (MeSH) Categories for verapamil hydrochloride

US Patents and Regulatory Information for verapamil hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Heritage Pharms Inc VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET;ORAL 071881-001 Apr 5, 1988 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Recro Gainesville VERELAN PM verapamil hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 020943-001 Nov 25, 1998 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Recro Gainesville VERELAN verapamil hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019614-003 Jan 9, 1992 AB RX Yes No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Industries VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET;ORAL 071489-001 Jan 13, 1988 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Marsam Pharms Llc VERAPAMIL HYDROCHLORIDE verapamil hydrochloride INJECTABLE;INJECTION 072233-001 Feb 26, 1993 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Watson Labs VERAPAMIL HYDROCHLORIDE verapamil hydrochloride TABLET;ORAL 071366-001 Oct 1, 1986 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira VERAPAMIL HYDROCHLORIDE verapamil hydrochloride INJECTABLE;INJECTION 070577-001 Feb 2, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Hospira VERAPAMIL HYDROCHLORIDE verapamil hydrochloride SOLUTION;INTRAVENOUS 070737-002 May 6, 1987 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold VERAPAMIL HYDROCHLORIDE verapamil hydrochloride INJECTABLE;INJECTION 070617-001 Nov 12, 1985 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Smith And Nephew VERAPAMIL HYDROCHLORIDE verapamil hydrochloride INJECTABLE;INJECTION 070697-001 Jul 31, 1987 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for verapamil hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle Llc COVERA-HS verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020552-002 Feb 26, 1996 ➤ Sign Up ➤ Sign Up
Gd Searle Llc COVERA-HS verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020552-001 Feb 26, 1996 ➤ Sign Up ➤ Sign Up
Gd Searle Llc COVERA-HS verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020552-001 Feb 26, 1996 ➤ Sign Up ➤ Sign Up
Recro Gainesville VERELAN verapamil hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019614-001 May 29, 1990 ➤ Sign Up ➤ Sign Up
Gd Searle Llc COVERA-HS verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020552-002 Feb 26, 1996 ➤ Sign Up ➤ Sign Up
Recro Gainesville VERELAN verapamil hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 019614-004 May 10, 1996 ➤ Sign Up ➤ Sign Up
Gd Searle Llc COVERA-HS verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020552-001 Feb 26, 1996 ➤ Sign Up ➤ Sign Up
Gd Searle Llc COVERA-HS verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020552-001 Feb 26, 1996 ➤ Sign Up ➤ Sign Up
Gd Searle Llc COVERA-HS verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020552-002 Feb 26, 1996 ➤ Sign Up ➤ Sign Up
Gd Searle Llc COVERA-HS verapamil hydrochloride TABLET, EXTENDED RELEASE;ORAL 020552-001 Feb 26, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
US Army
McKinsey
Boehringer Ingelheim
Baxter
UBS
Express Scripts
Teva
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot